Drug Type Biological products |
Synonyms |
Target |
Action inhibitors, antagonists |
Mechanism NGF inhibitors(Nerve growth factor inhibitors), TrkA antagonists(Nerve growth factor receptor Trk-A antagonists), p75NTR antagonists(Low affinity neurotrophin receptor p75NTR antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cancer Pain | IND Approval | China | 03 Jan 2024 |